𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lack of association between hla–dr2 and clinical response to methotrexate in patients with rheumatoid arthritis

✍ Scribed by Graciela S. Alarcóan; Lynn M. Billingsley; Daniel O. Clegg; Joe G. Hardin; John Klippel; Michael E. Luggen; Richard P. Polisson; Joyce Z. Singer; Lillian Szydlo; Robert F. Willkens; Ronald T. Acton; Bruce O. Barger; Stephen L. Dahl; William J. Koopman

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
291 KB
Volume
30
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of antiinfliximab antibodies
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
✍ Gerrit Jan Wolbink; Marijn Vis; Willem Lems; Alexandre E. Voskuyl; Els De Groot; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

## Abstract ## Objective Treatment of patients with infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This study evaluated the clinical significance of these antibodies in patients with rheumatoid arthr

Nonsteroidal antiinflammatory drug thera
Nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis patients. Lack of association between clinical improvement and effects on sleep
✍ P. Lavie; M. Nahir; M. Lorber; Y. Scharf 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB 👁 1 views

Thirteen patients with rheumatoid arthritis (mean & SD age 55.8 f 10.5 years) received 20 mg of tenoxicam daily for 90 days following a 3-7-day "washout" period and 4 days of placebo treatment. Clinical evaluations were conducted at the end of the washout period and at monthly intervals thereafter.